By Alexander Obermeyer.This year, the Intra-African Trade Fair is launching a new African Research and Innovation hub to foster collaboration between academia, industry, and policymakers across the ...

China Chengxin International Credit Rating Co., Ltd (CCXI) has assigned an ‘AAA/Stable’ rating to African Export-Import Bank (Afreximbank), recognising the Bank as a leading Multilateral Financial ...

U.S. President Donald Trump stressed the importance of India buying more American-made security equipment and moving toward a ...

By Ebenezer YALLEY Cross-border payments have become a convenient form of service for trade facilitation, scaling traditional modes of payment. Data compiled by Statista shows that in 2023, the total ...

A US Court of Appeals for the Federal Circuit panel consisting of Judges Sharon Prost, Richard Taranto, and Raymond Chen recently heard oral ...

As a result, the share of intra-African trade in total has declined to 14.4 per cent, from 14.7 per cent in 2022, according to a report by African Export-Import Bank (Afreximbank). In 2022, intra ...

"Marketplace" host Kai Ryssdal does an "exit interview" with Commerce Secretary Gina Raimondo. They talk AI, tariffs and more ...

The intra-Mediterranean trade sector has seen overall capacity ... Martin Gaard, CEO of Unifeeder A/S, commented: "The shipping industry is going through profound shifts, with geopolitical and ...

President Tinubu extensively enumerated the importance of intra-African trade and collaboration, calling on African leaders to prioritize initiatives that directly benefit the continent and its people ...

Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for major depressive disorder.

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday ... and interviews with industry experts. We also reference original research from other reputable publishers where ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) to Johnson & Johnson for $132.00 per ...